CareDx, Inc
- CDNA
- NASDAQ
- Medical - Diagnostics & Research
- Transplant Diagnostics
- Organ Transplant Monitoring
$67.08
Today +4.81%Quote Oct 19, 2026, 08:00 PM UTC
+17.91%over the last month
Max drawdown −10.9%From 1-month high −8.4%3 months +66.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About CareDx
CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers.
Where the money comes from
Q2 2026 revenue $131.9M
- Service$99.9M75.7%
- Product$12.8M9.7%
- Other / not reported$19.2M14.6%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Employees
763
Founded
1998
Market value
$3.47B
Quote Oct 19
Floor
$65.79
1.9% below price
Resistance
$68.94
2.8% above price
Price vs analyst targets
13 analysts
Lowest target
$46.00Highest target
$74.00
$46.00Highest target
$74.00
- Price $67.08
- Average target $62.25
- Analysts' target range
Analysts' average target sits about 7% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CDNAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free